在医疗保险人口中植入心房同步无室内心脏起器的患者的结果
George H Crossley1, Colleen Longacre2, Lucas Higuera2
1Vanderbilt University Medical Center, Nashville, Tennessee.
Heart rhythm
|September 24, 2023
概括
与静脉输入心脏起器相比,Micra AV无心脏起器显示了类似的30天并发症率和较低的6个月并发症和重新干预率. 尽管Micra AV患者具有更高的并发症负担,但这种情况发生了.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 医疗保健服务研究 医疗服务研究
背景情况:
- 迈克拉AV无线节奏系统是心律管理的新技术.
- 了解它在大量患者群体中的现实世界利用和结果至关重要.
研究的目的:
- 为了比较患者特征,并发症和Micra AV无心脏起器和传统的双室透静脉起器之间的结果.
- 分析美国医疗保险受益人的利用率和结果.
主要方法:
- 通过使用医疗保险索赔数据 (2020年2月 - 2021年12月),对7471个Micra AV植入物和107,800个双腔室透静脉起器植入物进行了回顾性分析.
- 评估30天的急性并发症和6个月的慢性并发症,重新干预和死亡率.
主要成果:
- 微型AV患者具有更高的并发症负担 (例如,末期脏病,更高的查尔森并发症指数).
- 在未调整的30天并发症率中没有显著差异;然而,Micra AV显示较低的调整的30天并发症率.
- 在6个月后,Micra AV表现出明显较低的并发症和重新干预的调整率.
结论:
- 微型AV无定律与可比的短期和改善的长期结果 (并发症,重新干预) 与输血定律相关.
- 这些好处甚至在与Micra AV植入的病态患者队列中也被观察到,突出其安全性和有效性.
相关概念视频
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Mitral Stenosis IV: Nursing Management
14
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
14
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
Heart Failure V: Medical Management
12
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
Mitral Valve Prolapse III: Nursing Management
16
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
16


